Stocks and Investing
Stocks and Investing
Mon, April 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, April 5, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Steven Lichtman Upgraded (ANGO) to Buy and Held Target at $12 on, Apr 5th, 2024
Steven Lichtman of Oppenheimer, Upgraded "AngioDynamics, Inc." (ANGO) to Buy and Held Target at $12 on, Apr 5th, 2024.
Steven has made no other calls on ANGO in the last 4 months.
There are 2 other peers that have a rating on ANGO. Out of the 2 peers that are also analyzing ANGO, 0 agree with Steven's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Steven
- Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $10 on, Tuesday, January 9th, 2024
- Yi Chen of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $18 on, Monday, January 8th, 2024
Contributing Sources